Ad26 Mos HIV trivalent vaccine

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameAd26 Mos HIV trivalent vaccine

Drug Alias NameAdenovirus-serotype-26-Mosaic-HIV-vaccine + Clade C glycoprotein 140Ad26.Mos.1.Env + Ad26.Mos1.Gag-Pol + Ad26.Mos2.Gag-PolAdenovirus-serotype-26-Mosaic-HIV-vaccineAd26 Mos HIV + clade C gp140Ad26.Mos.HIV + gp140 +[9]

ClassificationVaccines > Biological material > Viral vaccineVaccines > Application > Prophylactic vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsHIV Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryZambiaUnited StatesUganda +[10]

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesJohnson & Johnson Innovative Medicine

China Registration ClassN/A

Develop Information

Active CompaniesJanssen Vaccines & Prevention Bv

Inactive CompaniesN/A

Active IndicationsHIV Infections

Inactive IndicationsN/A

Other Information

ATC CodeN/A